Wednesday, 4 November 2026

Aggregated from Times of India, NDTV, Hindustan Times, India Today and more · Every source linked and credited · Updated every 15 minutes

Sharad Pawar discharged from Pune hospital after complaints of chest pain, cough SC upholds states’ power to levy additional sales tax, says case has become academic Cyclone Murasu weakens into deep depression, to become low-pressure area in 12 hours; IMD forecasts more rain in Andhra ‘Tired of using andhbhakts, godi?’: Shashi Tharoor says ‘quockerwodger’ an ‘acceptable alternative’IPL: MI, PBKS in talks over Hardik Pandya, Arshdeep Singh trade Hawaii’s tree snails return to wild after 33 years, with just 11 left in 1991 How London’s historic bridge ended up in the Arizona desert Pramila Jayapal To Ro Khanna: How Indian-Origin Faces Are Performing In US Elections Democrats Win Senate, End Republican Dominance In House. Trump Posts “Veto”Exclusive | ‘End Iran War, Lower Tariffs’: Suhas Subramanyam’s Goals After Big US Midterms Win

Sharad Pawar discharged from Pune hospital after complaints of chest pain, coughSC upholds states’ power to levy additional sales tax, says case has become academicCyclone Murasu weakens into deep depression, to become low-pressure area in 12 hours; IMD forecasts more rain in Andhra‘Tired of using andhbhakts, godi?’: Shashi Tharoor says ‘quockerwodger’ an ‘acceptable alternative’IPL: MI, PBKS in talks over Hardik Pandya, Arshdeep Singh tradeHawaii’s tree snails return to wild after 33 years, with just 11 left in 1991How London’s historic bridge ended up in the Arizona desertPramila Jayapal To Ro Khanna: How Indian-Origin Faces Are Performing In US ElectionsDemocrats Win Senate, End Republican Dominance In House. Trump Posts “Veto”Exclusive | ‘End Iran War, Lower Tariffs’: Suhas Subramanyam’s Goals After Big US Midterms Win

Markets

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

viaeconomictimes.indiatimes.com19 Oct

India’s pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceutical Industries and Aurobindo Pharma are likely to report good growth. In contrast, Dr Reddy’s Laboratories and Lupin may face challenges due to increased…

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.

Read the full story on economictimes.indiatimes.com ↗